Capital Flow Monitor · Sponsors · CIK 1289595
MAK One Fund LP
MAK CAPITAL ONE LLC, NEW YORK, NY, 10022 · 212-486-3291
Pooled Investment Fund / Hedge Fund · Limited Partnership· inc. DELAWARE true
Fit score
—
Offering
—
Sold
$894.9M
% sold
—
Investors
259
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-11-10 | D/A ·current | 506(b) | — | $894.9M | — | 259 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Michael Kaufman — Executive Officer, New York, NY
3 other raises
- Noveome Biotherapeutics, Inc. $6.8M of $15.0M · 45.0%
- Trailhead Biosystems Inc. $40.6M of $40.6M · 100.0%
- MAK Capital International Ltd $57.4M of —
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.